¿Es posible reducir la inflamación crónica en la infección por el virus de la inmunodeficiencia humana?
Rocafort, Muntsa; Paredes, Roger.
Med. clín (Ed. impr.)
; 142(2): 64-66, ene. 2014.
Artículo en Español | IBECS (España) | ID: ibc-118005
Documentos relacionados
Effects of okra (<i>Abelmoschus esculentus</i> L) on inflammatory mediators: a systematic review of preclinical studies.
Reflex principles of immunological homeostasis.
Mecanismos inflamatorios y fibróticos en la enfermedad renal. Protagonistas y terapéutica
Conformational pathology of the serpins: themes, variations, and therapeutic strategies.
Clinical control of asthma associates with measures of airway inflammation.
Mechanisms underlying inflammation in neurodegeneration.
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease.
Blood eosinophils, fraction of exhaled nitric oxide, and serum eosinophil cationic protein as surrogate markers for sputum eosinophils in asthma: influence of treatment with inhaled corticosteroids
Impact of Exercise on Inflammatory Mediators of Metabolic and Vascular Insulin Resistance in Type 2 Diabetes.
Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis.